Demonstrates a new transfer hydrogenation method, achieving selective reductions in unsaturated ketones, suggesting enhanced control over chemical reactions.
Decoupling proton and hydride delivery in transfer hydrogenation (TH) enables improved control over reactivity and selectivity, allowing mild reductions and site-specific deuterium incorporation beyond conventional single-donor systems. Herein, we report a rapid and highly chemoselective TH of α,β-unsaturated ketones using bench-stable, proton-responsive imidazole–phenol Ru(II)-p-cymene catalysts that operate via a dual-donor strategy, with methanol as the proton source and hydrosilanes as the hydride donor, enabling fast and selective C═C reduction at room temperature within 2–5 min. Reversible ligand switching in the bifunctional Ru(II) complex facilitates efficient metal–ligand cooperation, while a built-in chromatic response offers real-time visual end point detection and prevents over-hydrogenation. Detailed kinetic and spectroscopic analyses identify a silane-derived Ru–H active intermediate and demonstrate the crucial involvement of polar protic solvents in the rate-determining step. Control experiments indicate that selectivity arises from π-conjugation and carbonyl polarity, which facilitate substrate activation at Ru(II) and efficient proton-hydride transfer; the method also enables site-specific deuterium incorporation in saturated chalcones across diverse substrates. This dual-reagent strategy expands the reactivity of Ru(II)–arene complexes toward selective olefin reduction, while offering a practical, operationally simple protocol with built-in reaction control.
No takes yet. Share an insight, caveat, or question.
Padmor et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: